PathCision Medicine is harnessing tissue pathology insights to develop new targeted therapies. Built using a translational lens with a multi-omics approach, our proprietary discovery platform uncovers novel therapeutic avenues previously unavailable to patients with complex diseases. Our leading program is focused on developing a biologic modality for metastasis-selective delivery for multiple indications.
